.

ISSN 2063-5346
For urgent queries please contact : +918130348310

Comparative assessment of Fixed Dose Combinations of Indacaterol/Glycopyrronium versus Formoterol/Tiotropium in terms of Pulmonary Function Tests in mild to moderate Chronic Obstructive Pulmonary Disease patients: An Open Label Pilot Study

Main Article Content

Dr. Monika Verma1 , Dr.Himani Deswal2 , Dr.Suneel Kumar3 ,Dr. Pankaj Kaushik4 ,Dr.Sumit Kumar5 .
» doi: 10.48047/ecb/2023.12.8.772

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is a serious global healthcare problem. WHO predicts COPD as a leading cause of death by 2030. It is commonly diagnosed via spirometry also known as Pulmonary Function Test (PFT). Long Acting Beta Agonist/Long Acting Muscarinic Antagonist (LABA/LAMA) fixed dose combinations (FDC) remains the cornerstone in treatment of COPD. A FDC of IND/GLY was recently approved for COPD. This FDC induces dual bronchodilation.

Article Details